Safety profile of Infanrix hexa – 17 years of GSK’s passive post-marketing surveillance

References

• Esposito S, Tagliabue C, Bosis S, et al. Hexavalent vaccines for immunization in paediatric age. Clin Microbiol Infect. 2014;20(Suppl 5):76–85.
   PubMed Web of Science ®Google Scholar
• Zepp F, Schmitt HJ, Cleerbout J, et al., Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine). Expert Rev Vaccines. 2009;8(6): 663–678.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Infanrix hexa product information. [Cited 2018 Oct 16]. Available from: https://www.ema.europa.eu/documents/product-information/infanrix-hexa-epar-product-information_en.pdf
   Google Scholar
• Rennels MB. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis. 2003;14(3):196–198.
   PubMedGoogle Scholar
• Rennels MB, Deloria MA, Pichichero ME, et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics. 2000;105(1):e12.
   PubMed Web of Science ®Google Scholar
• Scheifele DW, Halperin SA, Ferguson AC. Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens. Vaccine. 2001;19(32):4720–4726.
   PubMed Web of Science ®Google Scholar
• Woo EJ, Burwen DR, Gatumu SN, et al. Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system. Clin Infect Dis. 2003;37(3):351–358.
   PubMed Web of Science ®Google Scholar
• Baldo V, Bonanni P, Castro M, et al., Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix hexa: twelve years of experience in Italy. Hum Vaccin Immunother. 2014;10(1): 129–137.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Ferro A, Guerra R, et al. Vaccine coverage in Italy and assessment of the 2012–2014 national immunization prevention plan. Epidemiol Prev. 2015;39(4 Suppl 1):146–158.
   PubMed Web of Science ®Google Scholar
• Paradowska-Stankiewicz I, Rudowska J. Pertussis in Poland in 2012. Przegl Epidemiol. 2014;68(2):205–207, 325–207.
   Google Scholar
• European Centre for Disease Prevention and Control. Pertussis. ECDC. Annual Epidemiological Report for 2016. [Cited 2019 Dec 4]. Available from: https://www.ecdc.europa.eu/sites/portal/files/documents/AER-for-2016-pertussis.pdf
   Google Scholar
• European Medicines Agency. Infanrix hexa: procedural steps taken and scientific information after the authorisation. [Cited 2019 Nov 19]. Available from: https://www.ema.europa.eu/en/documents/procedural-steps-after/infanrix-hexa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
   Google Scholar
• European Medicines Agency. Prevenar 13 product information. [Cited 2019 July 1]. Available from: https://www.ema.europa.eu/en/documents/product-information/prevenar-13-epar-product-information_en.pdf
   Google Scholar
• Jorch G, Tapiainen T, Bonhoeffer J, et al. Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25(31):5707–5716.
   PubMed Web of Science ®Google Scholar
• Mahaux O, Bauchau V, Van Holle L. Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines. Pharmacoepidemiol Drug Saf. 2016;25(2):215–222.
   PubMed Web of Science ®Google Scholar
• The Information System of the Federal Health Monitoring. Data from germany data sources of the federal statistical office. Statistics on the causes of death. Infant deaths (from 1998). [Cited Nov 2017]. Available from: http://www.gbe-bund.de/gbe10/pkg_isgbe5.prc_isgbe?p_uid=&p_aid=&p_sprache=E
   Google Scholar
• Centraal Bureau voor de Statistiek (CBS). Central bureau of statistics website. Themes. Health and welfare. Figures. Deaths by main primary cause of death & themes. [Cited Nov 2017]. Available from: https://www.cbs.nl/en-gb/society/health-and-welfare
   Google Scholar
• Institut National de la Santé et de la Recherche Médicale (INSERM). Centre d’Epidemiologie sur les causes Médicales de décès (CépiDc) - causes médicales de décès. [Cited Nov 2017]. Available from: http://www.cepidc.inserm.fr/
   Google Scholar
• Fine PE, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol. 1992;136(2):121–135.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC). Good practice guide on recording, coding, reporting and assessment of medication errors (EMA/762563/2014). [Cited 2019 Nov 19]. Available from: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-recording-coding-reporting-assessment-medication-errors_en.pdf
   Google Scholar
• Goldman SA. Limitations and strengths of spontaneous reports data. Clin Ther. 1998;20(Suppl C):C40–44.
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. ICH guideline E2C (R2) on periodic benefit-risk evaluation report (PBRER). [Cited 2019 Oct 18]. Available from: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-0.pdf
   Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), et al. Providing postmarketing periodic safety reports in the ICH E2C(R2) format (Periodic benefit-risk evaluation report): guidance for industry. [Cited 2019 Oct 18]. Available from: https://www.fda.gov/media/85520/download
   Google Scholar
• Brotherton JM, Hull BP, Hayen A, et al. Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia. Pediatrics. 2005;115(6):e643–646.
   PubMed Web of Science ®Google Scholar
• Moro PL, Arana J, Cano M, et al. Deaths reported to the vaccine adverse event reporting system, United States, 1997–2013. Clin Infect Dis. 2015;61(6):980–987.
   PubMed Web of Science ®Google Scholar
• Huang WT, Chen RT, Hsu YC, et al., Vaccination and unexplained sudden death risk in Taiwanese infants. Pharmacoepidemiol Drug Saf. 2017;26(1): 17–25.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Immunization Safety Review Committee. Immunization safety review: vaccinations and sudden unexpected death in infancy. Stratton, K, Almario, DA, Wizemann, TM, McCormick, MC (edited by). Washington (DC): The National Academy of Sciences; 2003.
   Google Scholar
• Moro PL, Perez-Vilar S, Lewis P, et al. Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines. Pediatrics. 2018;142:1.
   Web of Science ®Google Scholar
• Muller-Nordhorn J, Hettler-Chen CM, Keil T, et al. Association between sudden infant death syndrome and diphtheria-tetanus-pertussis immunisation: an ecological study. BMC Pediatr. 2015;15:1.
   PubMed Web of Science ®Google Scholar
• Vennemann MM, Butterfass-Bahloul T, Jorch G, et al. Sudden infant death syndrome: no increased risk after immunisation. Vaccine. 2007;25(2):336–340.
   PubMed Web of Science ®Google Scholar
• von Kries R. Comment on B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccination. Vaccine. 2006;24(31–32):5783–5784; author reply 5785–5786
   PubMed Web of Science ®Google Scholar
• von Kries R, Toschke AM, Strassburger K, et al. Sudden and unexpected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, Haemophilus influenzae type b): is there a signal? Eur J Pediatr. 2005;164(2):61–69.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global vaccine safety: six common misconceptions about immunization. [Cited 2019 Dec 4]. Available from: https://www.who.int/vaccine_safety/initiative/detection/immunization_misconceptions/en/index4.html
   Google Scholar
• Centers for Disease Control and Prevention. Vaccines and sudden infant death syndrome (SIDS). [Cited 2019 Dec 4]. Available from: https://www.cdc.gov/vaccinesafety/concerns/sids.html#rel
   Google Scholar
• European Medicines Agency. EMA public statement: EMA update on hexavalent vaccines: hexavac and Infanrix hexa. [Cited 2018 Oct 18]. Available from: https://www.ema.europa.eu/en/documents/public-statement/european-medicines-agency-public-statement-update-hexavalent-vaccines-hexavac-infanrix-hexa_en.pdf
   Google Scholar
• Moon RY, Fu L. Sudden infant death syndrome: an update. Pediatr Rev. 2012;33(7):314–320.
   PubMedGoogle Scholar
• Carlin RF, Moon RY. Risk factors, protective factors, and current recommendations to reduce sudden infant death syndrome: a review. JAMA Pediatr. 2017;171(2):175–180.
   PubMed Web of Science ®Google Scholar
• Vennemann MM, Findeisen M, Butterfass-Bahloul T, et al. Modifiable risk factors for SIDS in Germany: results of GeSID. Acta Paediatr. 2005;94(6):655–660.
   PubMed Web of Science ®Google Scholar
• Wang S, Tafalla M, Hanssens L, et al. A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Rev Vaccines. 2017;16(11):1095–1105.
   PubMed Web of Science ®Google Scholar
• Di Pasquale A, Bonanni P, Garcon N, et al., Vaccine safety evaluation: practical aspects in assessing benefits and risks. Vaccine. 2016;34(52): 6672–6680.
   PubMed Web of Science ®Google Scholar
• Edwards KM, Hackell JM. Countering vaccine hesitancy. Pediatrics. 2016;138:3.
   Web of Science ®Google Scholar
• Gidengil C, Chen C, Parker AM, et al. Beliefs around childhood vaccines in the United States: a systematic review. Vaccine. 2019;37(45):6793–6802.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Jarrett C, Eckersberger E, et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–2159.
   PubMed Web of Science ®Google Scholar
• McClure CC, Cataldi JR, O’Leary ST. Vaccine hesitancy: where we are and where we are going. Clin Ther. 2017;39(8):1550–1562.
   PubMed Web of Science ®Google Scholar
• Clarke KEN, MacNeil A, Hadler S, et al. Global epidemiology of diphtheria, 2000–2017(1). Emerg Infect Dis. 2019;25(10):1834–1842.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tetanus vaccines: WHO position paper - February 2017. Wkly Epidemiol Rec. 2017;92(6):53–76.
   PubMedGoogle Scholar